BioPharmSignal logoBioPharmSignal

Biotech News

Rani Therapeutics to Participate in the Chardan Healthcare Conference

Rani Therapeutics (RANI)Rani TherapeuticsConference / presentation

SAN JOSE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s management team will participate in a fireside chat at the upcoming Chardan

Related news

RANIRani Therapeutics2025-11-24 21:05 EST

Rani Therapeutics to Participate in the Evercore Healthcare Conference

RANIRani Therapeutics2026-08-10 12:00 EST

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

View all latest news

Rani Therapeutics

Oral Biologics Delivery Rani Therapeutics develops capsules that deliver biologic drugs through the intestinal wall, seeking to replace injections with oral administration. RaniPill Platform The RaniPill capsule protects its payload during passage through the stomach and deploys a microneedle-like mechanism in the small intestine. The...

Recent company news

RANIRani Therapeutics2026-10-13 20:05 EST

Rani Therapeutics to Participate in the Chardan Healthcare Conference

RANIRani Therapeutics2026-10-05 12:00 EST

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

RANIRani Therapeutics2026-09-08 12:00 EST

Rani Therapeutics to Participate in Upcoming September Conferences

RANIRani Therapeutics2026-08-13 20:05 EST

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

RANIRani Therapeutics2026-08-10 12:00 EST

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Stock data

Close
0.52 USD
Market cap
96.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States